000			01731 a2200457 4500
005			20250514063252.0
264		0	_c20060508
008			200605s 0 0 eng d
022			_a1744-7631
024	7		_a10.1517/14728222.7.2.165 _2doi
040			_aNLM _beng _cNLM
100	1		_aRich, Benjamin E
245	0	0	_aIL-20: a new target for the treatment of inflammatory skin disease. _h[electronic resource]
260			_bExpert opinion on therapeutic targets _cApr 2003
300			_a165-74 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650	0	4	_aAnimals
650	0	4	_aAutocrine Communication _xdrug effects
650	0	4	_aCell Differentiation _xdrug effects
650	0	4	_aCell Division _xdrug effects
650	0	4	_aCytokines _xphysiology
650	0	4	_aDermatitis _xdrug therapy
650	0	4	_aDrug Design
650	0	4	_aGene Expression Regulation _xdrug effects
650	0	4	_aHumans
650	0	4	_aImmunologic Factors _xpharmacology
650	0	4	_aInterleukins _xantagonists & inhibitors
650	0	4	_aKeratinocytes _xdrug effects
650	0	4	_aMice
650	0	4	_aModels, Biological
650	0	4	_aNF-kappa B _xphysiology
650	0	4	_aParacrine Communication _xdrug effects
650	0	4	_aPsoriasis _xdrug therapy
650	0	4	_aReceptors, Cytokine _xantagonists & inhibitors
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aT-Lymphocyte Subsets _ximmunology
650	0	4	_aTumor Necrosis Factor-alpha _xphysiology
650	0	4	_aViral Proteins _xchemistry
773	0		_tExpert opinion on therapeutic targets _gvol. 7 _gno. 2 _gp. 165-74
856	4	0	_uhttps://doi.org/10.1517/14728222.7.2.165 _zAvailable from publisher's website
999			_c12460359 _d12460359